Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND. J of Skin. 2024;8(1):s329. doi:10.25251/skin.8.supp.329